Nissan CEO got higher stock-linked bonus after payout date changed, former director Kelly says
Nissan Motor Co Ltd Chief Executive Hiroto Saikawa was granted an exception in 2013 to reschedule a stock-linked bonus that bumped up the payout by...
China’s Fosun holds talks to buy Thomas Cook’s main holiday business
The world’s oldest travel company Thomas Cook edged closer to a break up on Monday after its biggest shareholder, China’s Fosun Tourism, made a preliminary...
Renault rift with Nissan widens over governance, casts shadow on alliance
The two-decade-old partnership of Renault SA and Nissan Motor Co was plunged into fresh crisis on Monday, as the French automaker’s demand for a greater...
Oil steady with supply tight, but U.S.-China trade war threatens demand
Oil prices were steady on Monday as U.S.-China trade tensions continued to threaten demand for oil, but tight crude supply and the swift end to...
Thomas Cook in talks with China’s Fosun over tour operator sale
China’s Fosun Tourism has made a preliminary approach to Thomas Cook to buy its tour operator business, sending shares in the struggling British travel group...
Oil rises on supply cuts, but weak economy holds market back
Oil prices rose on Monday after Saudi Arabia said producer club OPEC and Russia should restrict supplies to current levels, while Washington’s withdrawal of a...
Renault, Nissan spar over governance reforms as tie-up strains worsen
Renault has signaled it will block alliance partner Nissan from adopting planned governance reforms unless the French automaker gets more say in the new system,...
Exclusive: FCA-Renault revival may hinge on Nissan stake cut – sources
Fiat Chrysler Automobiles NV and Renault SA are looking for ways to resuscitate their collapsed merger plan and secure the approval of the French carmaker’s...
Global stocks climb on trade, rate cut optimism; yuan falters
Asian shares, European and U.S. stock futures rose on Monday after the United States shelved plans to impose tariffs on Mexico and as global investors...
Roche’s $4.3 billion Spark bid delayed again amid U.S., UK scrutiny
Swiss drugmaker Roche’s $4.3 billion takeover of U.S. gene therapy specialist Spark Therapeutics has been pushed back again, possibly beyond the first half, as regulators...